Elderly Asians have a high burden of SVD which was associated with cognitive dysfunction. This suggests that SVD markers should be a potential target for treatment in clinical trials so as to delay progression of cerebrovascular disease and potentially cognitive decline.
Authors: Saima Hilal, Vincent Mok, Young Chul Youn, Adrian Wong, M. Kamran Ikram, Christopher Chen
DOI: https://doi.org/10.1136/jnnp-2016-315324
Publish Year: 2017
